舒弗美缓释片对严重慢性阻塞性肺疾病患者峰值呼气流速的影响  

Effect of Therophylline Slow-Releasing Pill on Severe Chronic Obstructive Pulmonary Disease Patients' Peak Expiratory Flow Rate

作　　者：李晓东[1] 高鸿美[2] 刘放[2] 

机构地区：[1]沈阳医学院奉天医院急诊科,辽宁沈阳110024 [2]沈阳医学院奉天医院呼吸科,辽宁沈阳110024

出　　处：《沈阳医学院学报》2005年第1期25-26,共2页Journal of Shenyang Medical College

摘　　要：目的:了解舒弗美缓释片对严重慢性阻塞性肺疾病的疗效。方法:对20例COPD患者使用舒弗美缓释片每日二次,每次200mg口服,连续治疗4周。结果:治疗后峰值呼气流速(peakexpiratoryflowrate,PEFR)比治疗前明显好转。治疗时间越长,改善越明显。医患双方时临床疗效评价的有效率分别为85%、80%。结论:使用舒弗美缓释片治疗COPD有良好的疗效。Objective:To explore the effect of theophylline slow-releasing pill on chronic obstructive pulmonary disease (COPD). Methods:Twenty patients were giver: therphylline slow releasing pill(200mg,bid) for 4 weeks continuously. Results:The peak expiratory flow rate(PEFR) was improved significantly after treatment, the effect was more significant than others when being treated for longer time. The valuable evaluation of doctors and patients to the drug were 85% and 80% respectively. Conclusion: There is a good effect to use theophylline slow-releasing pill to treat COPD.

关 键 词：峰值呼气流速 慢性阻塞性肺疾病患者 缓释片 舒弗美 严重慢性阻塞性肺疾病 COPD患者 临床疗效评价 连续治疗 rate 治疗时间 医患双方 治疗后 治疗前 有效率 

分 类 号：R563[医药卫生—呼吸系统] R563.05[医药卫生—内科学]